Moshe Gatt
0000-0002-9426-4482
6 papers found
Refreshing results…
Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study
Daratumumab for relapsed AL amyloidosis ‐ when cumulative real‐world data precedes clinical trials: A multisite study and systematic literature review
The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study
Real-World Data on Incidence, Clinical Characteristics and Outcome of Patients with Macrofocal Multiple Myeloma (MFMM) in the Era of Novel Therapies: A Study of the Greco-Israeli Collaborative Myeloma Working Group
Daratumumab resistance is frequent in advanced‐stage multiple myeloma patients irrespective ofCD38 expression and is related to dismal prognosis
Missing publications? Search for publications with a matching author name.